XXXX Thank today's our you, call. you Good on second provide then quarter more XXXX thank provide on and an joining everyone, for update morning, again details our first results and I'll financial Joe. outlook.
quarter strong our continued second XXXX We with financial performance. momentum
Sales of Pulse market impact the an delivered on year-over-year delivered year organic prior on the growth an and basis. the continue of to million InNeuroCo we versus the our fluctuations. expansion. year-over-year basis Adjusted more as income XX% on and the to compared growth operating $XX X% excludes or We margin Xx portable currency our $XXX recent X% and grew million sales $XX year, make of of up EBITDA, than adjusted rate increase of progress exit of foreign medical a which strategic acquisitions, reported million XX%. last
product second the XXXX approximately quarter year-over-year $XX XXXX. line sales a continued XX.X%, basis was our of Second XXX $X.XX a represents in XXXX for growth of year X-quarter delivering C&V sales, which and $X.XX share, the from represent net or strong ago. adjusted trailing approximately second on XXXX. versus of total the improvement basis of per operating XX% percent of of up income is Adjusted XX% CRM&N income quarter second of which sales, quarter quarter million, as adjusted points a earnings
XX% X XX% in CRM is Rhythm InNeuroCo sales can Pulse found high Vascular heart trailing PMA quarter growth X at and in D&V Management year-over-year. and new of integer.net. presentation, sales neuromodulation year-over-year, details Further line, growth from ramps electrophysiology product Cardiac Cardio and growth driven trailing double-digit quarter by and the product emerging appendix structural website increased across our and on acquisitions. the driven by be For the line & increased Neuromodulations all included double-digit customers. product single-digit markets, which growth are
primarily quarter improvements did by quarter In This operating we exchange. Strong $XX higher using second slightly million. include delivered capacity. interest net leverage of year. approximately quarter by operational higher by the due debt Technologies cost sales higher slightly total favorable period, and a adjusted basis, available approximately manufacturing tax Pulse expense offset million the we second balance XXXX. a and second a was tax-effected furthered partially adjusted XXXX, discussed and delivered revolver improved higher million rate million in is than last which interest totaling $X effective income and XXXX, foreign than the to our $X driven the during acquisitions previously On versus more average InNeuroCo expense $X adjusted This was efficiencies
the prior for Our the rate effective XX.X% adjusted quarter tax to year. was of second in compared XX.X% XXXX
Pillar effect tax member by rate primarily the effective driven slightly as year the adoption well compared minimum by residual the expiration. higher establishing framework effective the rate tax states, Malaysian to OECD of XX% tax of the a as the was X of Our adjusted holiday recent prior EU
and Year-over-year, by the receivable factoring operational flow we primarily In This $XX we approximately from the execution, accounts higher $XX million offset not repeat. approximately that was more improved XXXX, quarter second million million from from in sales margins. cash of XXXX second quarter of did generated cash generated operations. $XX
the was capital second was expenditures. In $XX second Ireland. year. XXXX, to in flow XXXX total, than support in million executed of lower continued the As investments, in quarter previously $X organic the cash capacity from our investing mentioned, prior we factoring And quarter investments operations million our
Our half invested have track on CapEx our second year in is approximately to In for in for spend the investments are the higher be the $XX year capacity half as Irish expected to million of our we expected million full complete. $XX lower XXXX, profile CapEx the CapEx expenditures the is and $XXX million. investment to first nearly
The XXXX. resulting free million, net quarter the to reduce was quarter by which compared improved $XX million second $XX which cash flow primarily first in to of the used total was debt,
X.Xx. As total at of range second a our end our within of trailing EBITDA, is to was net target which X.Xx debt the leverage adjusted quarter fourth strategic quarter the result, X.Xx
reiterating the XXXX strong and outlook XXXX our performance million. our our sales half increased from margin we by As income on profit With raising initiatives, operating outlook. range confidence Joe are manufacturing adjusted raising $X mentioned earlier, in have first we execution
Starting to $X.XXX organic with we X%. year, $X.XXX XXX XX% to to sales X%, underlying sales, rate to growth an above X% with continue our is billion estimate increase X% of versus market the growth range of expect basis deliver points billion, of in last to of which to X%
acquisitions, we growth. offset In the expect addition to contribute market organic in by to medical our portal organic the partially InNeuroCo and X% exit growth, Pulse
with million, which are outlook million $XXX $XXX EBITDA by to XX% up year-over-year XX% to a from guidance our of reflects growth. now range XX% our growth raising million. We adjusted of $X previous to XX% on
XX% sales operating to of million, outlook operating income between and income basis million year-over-year At Adjusted $X to as our $XXX XX% XX%. by a of to and outlook between of is income of million $XXX EPS our to $X.XX adjusted This grow XXXX. XXXX million year-over-year. a raising XX% X% year are million $XXX income expect to previous adjusted the $X.XX, be to be is We delivers percent growth year-over-year an X% the full growth $XXX is to reflecting and million, between adjusted compared which net operating from expected which of XXX is XX%. adjusted up reflecting $XXX growth midpoint, guidance XX%, points expected and expected to
into This to outlook offset and XX% the improvement dilution shares shares an from adjusted to effective average XX%. adjusted be projected of our an estimated is is adjusted XX.X initial XX%, dilutive between down by outstanding weighted rate, assumes million of of which Our notes. convertible tax outlook EPS effect taking in account XX%
of We higher be of Ireland result sales customer the from XXXX in and our new of second half XXXX to as product PMA first a emerging than expect the guidewire capacity half expansion increased ramps, growth.
expect increase of higher a We slightly than fourth XXXX. quarter sales quarter be the third with to in quarter, second the further
cash outlook. XXXX Moving to our
million flow cash of midpoint between X% from which an outlook. represents expect $XXX to $XXX year-over-year operations at increase We million,
we for million Our continue expenditures outlook $XXX to at capacity. capabilities to $XX million and remains as invest in organic capital
to between expect As $XX and flow million $XXX free generate a cash million. we result,
million net $X.XXX to year-end which billion billion, year-over-year. $XX to XXXX million total up is our We expect $X.XXX between $XX be and debt
expect the our year X quarter range of We adjusted end to to target within our ratio with X.X X.Xx leverage EBITDA. trailing
with back And Joe. I'll you. Thank turn the to that, call